Skip to main content
Fig. 1 | Cancer Communications

Fig. 1

From: Safety and efficacy of a modified XELOX adjuvant regimen for patients with operated stage III colon cancer: a Chinese single-center experience

Fig. 1

Kaplan-Meier curves of patients with stage III colon cancer grouped by modified XELOX, standard XELOX, and unfinished XELOX regimens. a Comparison of disease-free survival between the modified XELOX group and the unfinished XELOX group. b Comparison of overall survival between the modified XELOX group and the unfinished XELOX group. c Comparison of disease-free survival between the modified XELOX group and the standard XELOX group. d Comparison of overall survival between the modified XELOX group and the standard XELOX group. Abbreviations: XELOX, oxaliplatin and capecitabine regimen. DSF, disease-free survival; OS, overall survival

Back to article page

Cancer Communications

ISSN: 2523-3548

Contact us